£520.00

The 2023-2028 Outlook for Ophthalmic Anti-Inflammatory Pharmaceutical Drugs in the United States

Price data last checked 84 day(s) ago - refreshing...

View at Amazon

Price History & Forecast

Last 7 days • 7 data points (No recent data available)

Historical
Generating forecast...
£520.00 £494.00 £504.40 £514.80 £525.20 £535.60 £546.00 26 January 2026 27 January 2026 29 January 2026 30 January 2026 01 February 2026

Price Distribution

Price distribution over 7 days • 1 price levels

Days at Price
7 days 0 2 4 5 7 £520 Days at Price

Price Analysis

Most common price: £520 (7 days, 100.0%)

Price range: £520 - £520

Price levels: 1 different prices over 7 days

Product Specifications

Format
paperback
Domain
Amazon UK
Release Date
26 October 2022
Listed Since
10 November 2022

Similar Products You Might Like

The 2023-2028 World Outlook for Ophthalmic Anti-Inflammatory Pharmaceutical Drugs
99% match

The 2023-2028 World Outlook for Ophthalmic Anti-Inflammatory Pharmaceutical Drugs

£795.00 10 Mar 2026
The 2023-2028 Outlook for Anti-Inflammatory Lupus Drugs in the United States
97% match

The 2023-2028 Outlook for Anti-Inflammatory Lupus Drugs in the United States

£520.00 28 Jan 2026
The 2023-2028 Outlook for Anti-Inflammatory Asthma Drugs in the United States
97% match

The 2023-2028 Outlook for Anti-Inflammatory Asthma Drugs in the United States

£520.00 06 Feb 2026
The 2023-2028 Outlook for Anti-Inflammatory Scleroderma Drugs in the United States
97% match

The 2023-2028 Outlook for Anti-Inflammatory Scleroderma Drugs in the United States

£520.00 29 Jan 2026
The 2023-2028 Outlook for OTC Drugs in the United States
97% match

The 2023-2028 Outlook for OTC Drugs in the United States

£520.00 24 Jan 2026
The 2023-2028 Outlook for Antiviral Drugs in the United States
97% match

The 2023-2028 Outlook for Antiviral Drugs in the United States

£520.00 30 Jan 2026
The 2023-2028 Outlook for Over the Counter Drugs in the United States
97% match

The 2023-2028 Outlook for Over the Counter Drugs in the United States

£520.00 10 Dec 2025
The 2023-2028 Outlook for Anti-Malarial Drugs in the United States
97% match

The 2023-2028 Outlook for Anti-Malarial Drugs in the United States

£520.00 25 Jan 2026
The 2023-2028 Outlook for Topical Antiseptic Medications in the United States
97% match

The 2023-2028 Outlook for Topical Antiseptic Medications in the United States

£520.00 30 Jan 2026
The 2023-2028 Outlook for Advanced Therapy Medicinal Products in the United States
97% match

The 2023-2028 Outlook for Advanced Therapy Medicinal Products in the United States

£520.00 14 Jan 2026
The 2023-2028 Outlook for Uveitis Drugs in India
97% match

The 2023-2028 Outlook for Uveitis Drugs in India

£515.00 01 Feb 2026
The 2023-2028 Outlook for Antifungal Drugs in the United States
97% match

The 2023-2028 Outlook for Antifungal Drugs in the United States

£520.00 10 Dec 2025
The 2023-2028 Outlook for Optical Goods and Eye Care Products in the United States
97% match

The 2023-2028 Outlook for Optical Goods and Eye Care Products in the United States

£520.00 25 Jan 2026
The 2023-2028 Outlook for Vision Care in the United States
97% match

The 2023-2028 Outlook for Vision Care in the United States

£520.00 11 Jan 2026
The 2023-2028 Outlook for Anticoagulant Drugs in the United States
97% match

The 2023-2028 Outlook for Anticoagulant Drugs in the United States

£520.00 01 Feb 2026
The 2023-2028 Outlook for Eye Allergy Treatments in the United States
97% match

The 2023-2028 Outlook for Eye Allergy Treatments in the United States

£520.00 24 Jan 2026
The 2023-2028 Outlook for Allergy Relieving Eye Drops in the United States
97% match

The 2023-2028 Outlook for Allergy Relieving Eye Drops in the United States

£520.00 22 Jan 2026
The 2023-2028 Outlook for Opioid Drugs in the United States
97% match

The 2023-2028 Outlook for Opioid Drugs in the United States

£520.00 07 Feb 2026
The 2023-2028 Outlook for Dry Eye Syndrome Treatments in the United States
97% match

The 2023-2028 Outlook for Dry Eye Syndrome Treatments in the United States

£520.00 25 Jan 2026
The 2023-2028 Outlook for Optic Nerve Disorders Treatments in the United States
97% match

The 2023-2028 Outlook for Optic Nerve Disorders Treatments in the United States

£520.00 14 Jan 2026
The 2023-2028 Outlook for Myeloproliferative Disorder Drugs in the United States
97% match

The 2023-2028 Outlook for Myeloproliferative Disorder Drugs in the United States

£520.00 06 Feb 2026
The 2023-2028 Outlook for Insomnia Drugs in the United States
97% match

The 2023-2028 Outlook for Insomnia Drugs in the United States

£520.00 25 Jan 2026
The 2023-2028 Outlook for Infertility Drugs in the United States
97% match

The 2023-2028 Outlook for Infertility Drugs in the United States

£520.00 21 Jan 2026
The 2023-2028 Outlook for Prostaglandin Glaucoma Therapeutics in the United States
97% match

The 2023-2028 Outlook for Prostaglandin Glaucoma Therapeutics in the United States

£520.00 07 Feb 2026